Home | Supplements | Volume 53 | This supplement | Article number 1

Case study

Cutaneous leishmaniasis surveillance report in Saudi Arabia, 2017-2018

Cutaneous leishmaniasis surveillance report in Saudi Arabia, 2017-2018

Hakami Bassam1,&, Yahya AlAsseri2, Almutairi Abdulaziz3, Kamel Shady4, Abd-Ellatif Eman5

 

1Field Epidemiology Training Program, Riyadh, Saudi Arabia, Jazan Health Cluster, Jazan, Saudi Arabia, 2Public Health Deputyship, Ministry of Health, Riyadh, Saudi Arabia, 3Field Epidemiology Training Program, Ministry of Health, Riyadh, Saudi Arabia, 4Field Epidemiology Training Program, Public Health Agency, Saudi Ministry of Health, Riyadh, Saudi Arabia, 5Department of Public Health and Community Medicine, Faculty of Medicine, Mansoura University, Egypt

 

 

&Corresponding author
Hakami Bassam, Field Epidemiology Training Program, Riyadh, Saudi Arabia; Jazan Health Cluster, Jazan, Saudi Arabia

 

 

Abstract

Leishmaniasis is a protozoal disease caused by more than 20 Leishmania species. Over 90 sandfly species are known to transmit Leishmania parasites. There are three main forms of the disease including visceral, cutaneous, and mucocutaneous. In Saudi Arabia, cutaneous leishmaniasis (CL) poses a persistent public health challenge, despite efforts to control it. The aim of this study is to describe the demographic and geographic characteristics of Cutaneous Leishmaniasis cases reported by the national surveillance in Saudi Arabia in 2017 and 2018. Data obtained from the Health Electronic Surveillance Network (HESN) for confirmed CL cases across Saudi Arabia. The analysis included variables such as age, gender, nationality, region, diagnosis date, and epidemiological week. A total of 827 cases were included, with 397 cases in 2017 and 430 cases in 2018. Ahsa had the highest rates in both years. Most cases were males (81.86%), with a mean age of 29.98 years. CL was more common among Saudi nationals (51.15%) than other nationalities, and cases peaked in February and were lowest in July. The highest number of CL reported in the Western and Eastern regions of Saudi Arabia. National and regional studies are needed to guide the development of evidence-based diagnostic and management guidelines for CL control.

 

 

How to use this case study    Down

General instructions: this case study should be used as adjunct training material for novice epidemiology trainees to reinforce the concepts taught in prior lectures. The case study is ideally taught by a facilitator in groups of about 20 participants. Participants required to take turns reading the case study, usually a paragraph per student. The facilitator guides the discussion on responses to questions. The facilitator may make use of flip charts to illustrate certain points. Additional instructor's notes for facilitation are coupled with each question in the instructor's guide to aid facilitation.

Audience: this case study was developed for novice field epidemiology students. These participants are commonly health care workers working in the county departments of health whose background may be as medical doctors, nurses, environmental health officers or laboratory scientists who work in public health-related fields. Most have a health science or biology background.

Prerequisites: before using this case study, participants should have received lectures on disease surveillance and outbreak investigation.

Level of training and associated public health activity: Novice - surveillance investigation.

Time required: 2-3 hours

Language: English

 

 

Case study material Up    Down

 

 

Competing interests Up    Down

The authors declare no competing interests.

 

 

References Up    Down

  1. NIAID Now. World Neglected Tropical Diseases Day - Focus on Leishmaniasis. National Institute of Allergy and Infectious Diseases. Accessed on 14 Aug, 2024.

  2. WHO. Leishmaniasis. World Health Organization. Accessed on 14 Aug, 2024.

  3. Mann S, Frasca K, Scherrer S, Henao-Martínez AF, Newman S, Ramanan P, Suarez JA. A review of leishmaniasis: current knowledge and future directions. Curr Trop Med Rep. 2021;8(2):121-132. PubMed | Google Scholar

  4. Abass E, Al-Hashem Z, Yamani LZ. Leishmaniasis in Saudi Arabia: current situation and future perspectives. Pak J Med Sci. 2020 May-Jun;36(4):836-842. PubMed | Google Scholar

  5. Kumosani TA, Al-Bogami TJ, Barbour EK, Alshehri SH, Yaghmoor SS, Alshareef NA, El-Say KM, Moselhy SS. Leishmaniasis prevalence, awareness and control in Saudi Arabia. Afr Health Sci. 2022 Sep;22(3):640-647. PubMed | Google Scholar

  6. Al-Dhafiri M, Alhajri A, Alwayel ZA, Alturaiki JA, Bu Izran SA, Alhammad FA, Aljumaiah RM. Cutaneous leishmaniasis prevalence and clinical overview: a single-center study from Saudi Arabia, Eastern Region, Al-Ahsa. Trop Med Infect Dis. 2023 Nov 24;8(12):507. PubMed | Google Scholar

  7. Abuzaid AA, Abdoon AM, Aldahan MA, Alzahrani AG, Alhakeem RF, Asiri AM, Alzahrani MH, Memish ZA. Cutaneous leishmaniasis in Saudi Arabia: a comprehensive overview. Vector Borne Zoonotic Dis. 2017 Oct;17(10):673-684. PubMed | Google Scholar

  8. Ahmed Zakai H. Cutaneous Leishmaniasis (CL) in Saudi Arabia: Current Status. January 2014. Accessed on 14 Aug, 2024.

  9. Abdalla NM, Abdelgani AM, Osman AA, Mohamed MN. Demographical and population dynamics impact on public health of cutaneous leishmaniasis in Al-Madinah Almonawra, Saudi Arabia. Afr Health Sci. 2019 Sep;19(3):2421-2430. PubMed | Google Scholar

  10. Ministry of Health, Public Health Deputyship, Saudi Arabia. Cutaneous Leishmaniasis Management Guide. 2019. Accessed on 14 Aug, 2024.